In the BioHarmony Drug Report Database

"Preview" Icon

Guanidine

Guanidine (guanidine) is a small molecule pharmaceutical. Guanidine was first approved as Guanidine on 1982-01-01. It is used to treat lambert-eaton myasthenic syndrome and muscle weakness in the USA. It is known to target acid-sensing ion channel 3 and nitric oxide synthase, inducible.

 

Trade Name

 

Guanidine
 

Common Name

 

guanidine
 

ChEMBL ID

 

CHEMBL821
 

Indication

 

lambert-eaton myasthenic syndrome, muscle weakness
 

Drug Class

 

Antihypertensives (guanidine derivatives)

Image (chem structure or protein)

Guanidine structure rendering